|
Volumn 70, Issue 4 SUPPL., 1992, Pages 913-920
|
Hematopoietic colony-stimulating factors: Uses in combination with standard chemotherapeutic regimens and in support of dose intensification
|
Author keywords
breast cancer; chemotherapy; dose intensity; G CSF; GM CSF; hematopoietic cytokines; lymphoma
|
Indexed keywords
CISPLATIN;
COLONY STIMULATING FACTOR;
CYCLOPHOSPHAMIDE;
CYTOKINE;
ETOPOSIDE;
GRANULOCYTE COLONY STIMULATING FACTOR;
GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;
ARTICLE;
BONE MARROW SUPPRESSION;
BONE MARROW TRANSPLANTATION;
BREAST CANCER;
CANCER;
CANCER CHEMOTHERAPY;
CANCER REGRESSION;
CANCER SURVIVAL;
CELL LINE;
DOSE RESPONSE;
ERYTHEMA;
FATIGUE;
HEMATOPOIESIS;
HUMAN;
INFLUENZA;
INTRAVENOUS DRUG ADMINISTRATION;
LEUKOPENIA;
NONHODGKIN LYMPHOMA;
PERICARDIAL EFFUSION;
PLEURA EFFUSION;
PRIORITY JOURNAL;
STEM CELL;
THROMBOSIS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BONE MARROW TRANSPLANTATION;
CYTOKINES;
DOSE-RESPONSE RELATIONSHIP, DRUG;
GRANULOCYTE COLONY-STIMULATING FACTOR;
GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR;
HUMAN;
NEOPLASMS;
|
EID: 0026622884
PISSN: 0008543X
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (24)
|
References (0)
|